Navigation Links
HIV Drug May Prevent Bone Marrow Transplant Complication
Date:7/11/2012

WEDNESDAY, July 11 (HealthDay News) -- An HIV drug significantly reduced the risk of graft-versus-host disease, an all-too-common complication in blood cancer patients following bone marrow transplants, new research finds.

Bone marrow is the spongy tissue inside the bones that contains immature cells, or stem cells. In an "allogeneic" bone marrow transplantation, also called a stem cell transplant, a patient's own stem cells and immune system are wiped out by chemotherapy and radiation. Then, the patient receives the transplant, or bone marrow, from a closely matched donor.

The treatment is used for several types of blood cancers, including lymphoma and leukemia.

But a common complication of a bone marrow transplant is graft-versus-host disease. It occurs when transplanted immune cells attack patients' healthy tissue, a complication that can be minor or life-threatening.

"Graft-versus-host disease affecting the skin, liver, gut and other organs is a dreaded complication of allogeneic stem cell transplantation either from a related or unrelated donor," said one expert, Dr. Jasmine Zain of NYU Langone Medical Center in New York City. "The rates are 35 percent with related donors and up to 57 percent by day 100, even in reduced-intensity transplants," added Zain, who is director of the Bone Marrow Transplant Program and assistant professor in the division of hematologic malignancies and medical oncology at the center.

The study was conducted by a team at the University of Pennsylvania's Perelman School of Medicine and included 38 patients with several types of blood cancers. The cancers included acute myeloid leukemia, myelodysplastic syndrome, lymphoma and myelofibrosis. All of the patients were given the drugs tacrolimus and methotrexate, which suppress the immune system and are a standard treatment to prevent graft-versus-host disease.

The patients were also given a 33-day course of the HIV drug, mara
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Studies Show Value of AIDS Drugs as Prevention
2. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
3. Identifying risky behaviors: The key to HIV prevention
4. New study suggests moderate alcohol consumption may help prevent bone loss
5. Interactive personal health records increase clinical preventive services
6. U.S. High Schools Lax in Preventing Dating Abuse: Study
7. Prevention is better than cure for killer cardiovascular disease
8. Higher Doses of Vitamin D Prevent Fractures in Older Women
9. Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug
10. The prevention of hereditary breast and ovarian cancer by PGD is feasible
11. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug May Prevent Bone Marrow Transplant Complication
(Date:3/5/2015)... This week, 60 Minutes ... laminate flooring products, initiating widespread concern from homeowners. ... materials made primarily from bamboo, stands behind their ... flooring products for volatile organic compounds (VOCs) through ... (BMH). Results from formaldehyde emissions testing show ...
(Date:3/5/2015)... 05, 2015 Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ... heart attacks, strokes and other serious cardiovascular events due ... to move forward in the federal multidistrict litigation now ... According to a Case Management Order issued on March ... use of master pleadings in the proceeding. Among other ...
(Date:3/5/2015)... The Maricopa Community Colleges add $7.3 ... economy each year, according to a research report released ... Maricopa County Community College District, summarizes economic impact and ... year 2013-2014. , The analysis was conducted by ... that specializes in providing economic impact studies and labor ...
(Date:3/5/2015)... TCS Healthcare Technologies (TCS), a leading provider of ... arena, is pleased to announce a webinar focusing on ... (ACUITY) version 7.20. The session will focus on the ... automation. , The webinar, scheduled for March 18, 2015 ... Frater, RN, BSN, Director of Partner Development at TCS. ...
(Date:3/5/2015)... 2015 Califia Farms , the ... natural products coffee drinks category[1], today unveils its new ... in Anaheim, Calif. Concentrated Cold Brew (CCB) is ... which democratizes the next wave of the coffee-taste evolution ... to become their own baristas. , Califia Farms ...
Breaking Medicine News(10 mins):Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4
... Palmer Hospital, are hosting Grossology, an interactive exhibit designed to teach ... ... (PRWEB) January 29, 2009 -- The Orlando Science Center and presenting ... Science of the Human Body, a colorful, hands-on exhibit that uses ...
... funding research for the genetic disorder cystinosis, unveils new communication ... ... Forest, IL (PRWEB) January 29, 2009 -- The Cystinosis Research ... for the rare genetic disorder cystinosis, has launched a new ...
... CHARENTON-LE-PONT, France, January 29 , - A New ... 9.7% Excluding the Currency Effect, - Higher Earnings ... in ophthalmic optics, today,announced consolidated revenue of EUR3,074.5 million for the ... previous,year. Excluding the currency effect, growth for the year was a ...
... OH, January 29, 2009 -- Recent studies have suggested ... among children born very prematurely. The early symptoms ... to preterm births, such as cerebral palsy, which can ... Because of this, researchers have begun to explore ...
... "super bugs" because our antibiotic arsenal has run dry, leaving ... infectious disease researchers at The University of Texas Medical School ... The New England Journal of Medicine , Barbara E. Murray, ... and future response to preventing and treating "super bugs." , ...
... Dramatic New Study Presented in Congressional Briefing TodayOAKLAND, ... which Congress prepared to vote on the Obama ... nation,s largest organization of registered nurses said expanding ... of the most effective economic recovery programs - ...
Cached Medicine News:Health News:Grossology Exhibit Captivates Kids at The Orlando Science Center 2Health News:Grossology Exhibit Captivates Kids at The Orlando Science Center 3Health News:Cystinosis Research Network Unveils New Communication Strategy and Website 2Health News:Essilor : 2008 Revenue 2Health News:Essilor : 2008 Revenue 3Health News:Essilor : 2008 Revenue 4Health News:Essilor : 2008 Revenue 5Health News:Essilor : 2008 Revenue 6Health News:New study explores the relationship between preterm birth and autism spectrum disorder 2Health News:Call to action: Running out of options to fight ever-changing 'super bugs' 2Health News:Call to action: Running out of options to fight ever-changing 'super bugs' 3Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 2Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 3
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Japan Pharma Outlook 2015: Year to Watch out ... report to their offering. The ... from April -2014 (Annexure 1) is a game ... whether generic or innovator. The most of the companies ...
(Date:3/5/2015)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... be held March 8-11, 2015, in Laguna ... , Chief Executive Officer, will provide an overview of ... be available to participate in one-on-one meetings with investors ...
(Date:3/5/2015)... -- According to a new market research ... Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User ... - Analysis & Global Forecast to 2019" , the ... $1,107.4 Million by 2019 from $887.8 Million in 2014, ... 4.5% during the forecast period. Browse ...
Breaking Medicine Technology:Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... 3, 2012 Cardium Therapeutics (NYSE Amex: ... with NYSE Amex LLC (formerly the American Stock Exchange). ... now in excess of the threshold requirements under Section ... (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ...
... Calif., Jan. 3, 2012 BioMarin Pharmaceutical Inc. (Nasdaq: ... New Drug (IND) application for BMN-111, an analog of ... company expects to initiate the Phase 1 trial in ... demonstrated benefits in moderately and severely affected animal models ...
Cached Medicine Technology:Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 2Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 3Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 4BioMarin Announces IND for BMN-111 for Achondroplasia is Active 2BioMarin Announces IND for BMN-111 for Achondroplasia is Active 3BioMarin Announces IND for BMN-111 for Achondroplasia is Active 4
Intended for the quantitative determination of total protein in serum. Reaction: endpoint. Wavelength: 540 nm. Linearity: 12 g/dL (120 g/L). Ready to use liquid reagent....
For the determination of urea nitrogen in human serum....
... Intended for the quantitative determination ... Reaction: kinetic, lag phase of ... by linear phase of at ... nm. Linearity: 120 mg/dL (42.8 ...
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
Medicine Products: